Guidant, J&J Agree To Arbitrate Suits, Exchange Licenses And Technology
This article was originally published in The Gray Sheet
Executive Summary
Guidant will evaluate in preclinical studies electronic field stimulation (EFS) technology gained through an agreement with Johnson & Johnson before deciding whether to incorporate it into its biventricular pacing device to treat congestive heart failure, the firm says.